Newsroom

LINZ, Autriche--(BUSINESS WIRE)--Fabasoft, l'un des principaux fournisseurs européens de solutions cloud pour la gestion des documents et des processus métier, a été classé « Challenger » par Gartner® dans son premier Magic Quadrant™ 2026 pour les logiciels de gestion de la qualité, grâce à son produit Fabasoft Approve. Dans son rapport, le cabinet d'analystes reconnaît les points forts et les points faibles de l'entreprise. « Gartner définit le marché des logiciels de gestion de la qualité (QM...

LINZ, Oostenrijk--(BUSINESS WIRE)--Fabasoft, een toonaangevende Europese cloudleverancier voor document- en bedrijfsprocesbeheer, is door Gartner® in zijn eerste 2026 Magic Quadrant™ voor kwaliteitsmanagementsysteemsoftware gepositioneerd als Challenger voor zijn product Fabasoft Approve. In het rapport erkent het analistenbureau de sterke punten en waarschuwt het voor de zwakke punten van het bedrijf. “Gartner definieert de markt voor kwaliteitsmanagementsysteemsoftware (QMS/eQMS) als zelfstan...

AUSTIN, Texas--(BUSINESS WIRE)--Ambiq Micro, Inc. (“Ambiq”) (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the pricing of its upsized underwritten public offering of 2,679,600 shares of its common stock at a public offering price of $31.00 per share. 2,636,651 shares of common stock are being offered by Ambiq, and 42,949 shares of common stock are being offered by certain of Ambiq’s stockholders. The gross proceeds to Ambiq from the off...

HANOI, Vietnam--(BUSINESS WIRE)--Global technology and IT services provider FPT and South Korean leading AI transformation (AX) company LG CNS announced a strategic partnership to jointly expand AI-powered education and training solutions across Vietnam and the broader Southeast Asia market. The partnership will combine LG CNS’s AI-powered education solutions with FPT’s global presence, market access, and local capabilities to address growing demand for technology-enabled learning across the re...

DEERFIELD, Ill.--(BUSINESS WIRE)--As severe winter storms and dangerously cold temperatures are forecasted across the country this weekend, Walgreens is taking proactive steps to support the safety and well-being of its patients, team members and communities. Walgreens is monitoring the trajectory of winter storms closely and encourages all team members and patients in the impacted regions to follow guidance from local authorities and prioritize their safety and well-being. In preparation, we a...

MILAN--(BUSINESS WIRE)--Tinaba with Banca Profilo announces launch of digital payments in the Chinese mainland through the extension of its strategic partnership with Alipay+...

倫敦--(BUSINESS WIRE)--(美國商業資訊)-- 擁有創新研發管線的臨床階段腫瘤藥物開發公司Ellipses Pharma Limited（Ellipses）宣布已與Innolake Biopharm Co. Ltd（英諾湖）達成合作及授權協議，共同開發一款臨床階段的首創抗體藥物偶聯物（ADC）。 根據合作協議，Ellipses獲得除大中華區以外的全球範圍內開發標靶B7H3的ADC（以艾立布林為有效載荷，產品名為ILB-3101）的權利。ILB-3101有望用於治療多種腫瘤類型，並克服拓樸異構酶I類ADC的抗藥性。Ellipses將ILB-3101命名為EP0028。 Ellipses和英諾湖將緊密合作開發ILB-3101/EP0028，該藥物目前正在中國進行由英諾湖贊助的I期臨床試驗。Ellipses將在美國啟動其I期臨床試驗，並在獲得相關監管部門批准後，將試驗擴展至歐洲及其他地區。 EP0028是Ellipses臨床階段產品線的重要補充，也是Ellipses從中國創新生物技術公司引進的第二個計畫。首個計畫EP0031是由科倫博泰開發的新一代選擇性RET抑制劑，Elli...

HOUSTON--(BUSINESS WIRE)--Geospace will release first quarter earnings on February 4, 2026....

DENVER--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), un pioniere globale nella tecnologia a laser blu ad alte prestazioni, oggi ha annunciato di essersi assicurato il controllo operativo di Orbit S.r.l. (“Orbit”), redditizia azienda fornitrice di Software-as-a-Service (“SaaS”), incentrata sulla resilienza operativa, l'intelligenza del rischio e il supporto delle decisioni mission-critical. La transazione rafforza le capacità di sicurezza di NUBURU e promuove la strategia di crescita mul...

ABU DHABI, Emirati Arabi Uniti--(BUSINESS WIRE)--Il Programma di ricerca degli Emirati Arabi Uniti per la scienza dell'intensificazione delle precipitazioni (UAEREP), gestito dal Centro nazionale di meteorologia (NCM), ha annunciato i vincitori delle borse di ricerca del sesto ciclo. Ogni vincitore riceverà fino a 1,5 milioni di dollari statunitensi nell'arco di tre anni, con assegnazioni annuali fino a un massimo di 550.000 dollari statunitensi. I vincitori del sesto ciclo sono il dott. Dixon...